Contrarily, individuals clinically diagnosed with Alzheimer’s disease and comorbid diabetes, who have been subjected to insulin and oral medication regimens, have a markedly relieved amyloid pathology compared to those without Alzheimer’s disease or concomitant diabetes17,18. This evidence concerns the gene INS and diabetes mellitus.